Year archive

4SC AG — 2012 filings

All 67 regulatory filings released by 4SC AG (VSC) in 2012, sourced directly from the official regulator.

67 Filings

2012 Period

2012 filings (67)

Filing	Released	Lang
Konzernabschluss zum Geschäftsjahr vom 01.01.2011 bis zum 31.12.2011 Audit Report / Information FY 2011	2012-12-20	German
Jahresabschluss zum Geschäftsjahr vom 01.01.2010 bis zum 31.12.2010 Audit Report / Information FY 2010	2012-12-18	German
Press Release: 4SC Discovery and BioNTech announce exclusive research and license agreement for 4SC's TLR agonists for cancer immunotherapy Regulatory Filings	2012-12-17	English
Press Release: 4SC announces positive interim results from clinical Phase I/II trial with anti-cancer compound resminostat in colorectal cancer Regulatory Filings	2012-12-12	English
Press Release: 4SC reports positive data from clinical Phase I trial with 4SC-205 in cancer patients and initiates study amendment Regulatory Filings	2012-12-05	English
Q3 Report 2012 Interim / Quarterly Report 9M 2012	2012-11-19	English
Press Release: 4SC receives patent protection for its epigenetic anti-cancer compound 4SC-202 in Japan and other Asian growth markets Regulatory Filings	2012-11-12	English
Press Release: 4SC's successful development continues in third quarter of 2012 Earnings Release 9M 2012	2012-11-08	English
Press Release 4SC: Clinical data with 4SC's compound Vidofludimus in inflammatory bowel disease published in peer-reviewed scientific journal Regulatory Filings	2012-11-02	English
4SC to host conference call on 8 November 2012 to present Q3 2012 results Report Publication Announcement	2012-11-01	English
Press Release: 4SC Discovery receives research grant of EUR 600,000 for development of personalised cancer drugs Regulatory Filings	2012-10-23	English
Press Release: 4SC obtains key patent for anti-cancer compound resminostat in China Regulatory Filings	2012-10-01	English
Press Release: 4SC Discovery to host Symposium 'Drug Discovery in the Age of Epigenetics' on 24 September 2012 Regulatory Filings	2012-09-21	English
Press Release: 4SC's Anti-Cancer Drug Resminostat achieves Median Overall Survival of 8.0 Months in Second-Line Advanced Liver Cancer (HCC) Patients Earnings Release Q3 2012	2012-09-13	English
4SC's Anti-Cancer Drug Resminostat achieves Median Overall Survival of 8.0 Months in Second-Line Advanced Liver Cancer (HCC) Patients Regulatory Filings	2012-09-13	English
Q2 Report 2012 Interim / Quarterly Report H1 2012	2012-08-22	English
Press Release: 4SC's successful start to the year continues in Q2 of 2012 Earnings Release H1 2012	2012-08-09	English
Press Release: 4SC AG further strengthens Supervisory Board with experienced managers from the pharmaceutical industry Board/Management Information	2012-08-06	English
Announcement: 4SC to host conference call on 9 August 2012 to present Q2 2012 results Report Publication Announcement	2012-08-02	English
4 SC AG: Veroffentlichung gema 26a Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung Declaration of Voting Results & Voting Rights Announcements	2012-07-31	German
Press Release: 4SC Discovery, Crelux and Ribological launch collaboration for the discovery and optimisation of new anti-cancer drugs Regulatory Filings	2012-07-17	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-07-09	German
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-07-09	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-07-09	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-07-05	German
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-07-05	German
DGAP-DD: 4SC AG english Director's Dealing	2012-07-04	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-07-02	German
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-07-02	German
4SC AG: Volume of capital increase determined at 8,403,510 new shares, gross proceeds of EUR 12,605,265.00 expected Capital/Financing Update	2012-06-29	English
Capital increase 4SC AG: subscription offer period ended, rump placement started Share Issue/Capital Change	2012-06-29	English
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 06.08.2012 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2012-06-28	German
Press Release: 4SC to present additional safety and efficacy data for cancer drug Resminostat from its Phase II SHELTER trial in liver cancer Regulatory Filings	2012-06-28	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-06-22	German
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-06-22	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-06-22	English
Press Release: 4SC's lead autoimmune product vidofludimus shows convincing preclinical evidence in a kidney transplantation model Regulatory Filings	2012-06-18	English
Press Release: 4SC to present biomarker data for cancer drug Resminostat from Phase II trial in Hodgkin's lymphoma Regulatory Filings	2012-06-15	English
Ad-hoc-Release: 4SC AG capital increase - resolution on further details Capital/Financing Update	2012-06-13	English
Press Release: 4SC AG announces election of Dr Thomas Werner to chairman of the Supervisory Board Board/Management Information	2012-06-13	English
Ad hoc release: 4SC AG resolves on capital increase Capital/Financing Update	2012-06-13	English
Press Release: 4SC's anti-cancer drug resminostat achieves progression-free survival of 4.7 months in Phase II trial in advanced liver cancer (HCC) Earnings Release Q2 2012	2012-05-31	English
Press Release 4SC AG: 4SC's partner Yakult Honsha starts clinical development with cancer compound resminostat in Japan Legal Proceedings Report	2012-05-15	English
Press Release 4SC AG: 4SC Announces Financial Results for the First Quarter of 2012 Earnings Release Q1 2012	2012-05-10	English
Konzernabschluss zum Geschäftsjahr vom 01.01.2011 bis zum 31.12.2011 Annual Report FY 2011	2012-05-10	German
Q1 Report 2012 Interim / Quarterly Report Q1 2012	2012-05-10	English
Jahresabschluss zum Geschäftsjahr vom 01.01.2011 bis zum 31.12.2011 Annual Report FY 2011	2012-05-07	German
4SC to host conference call on 10 May 2012 to present Q1 2012 financial results Report Publication Announcement	2012-05-04	English
Press Release 4SC AG: Dr Jorg Neermann announces resignation from Supervisory Board of 4SC AG Board/Management Information	2012-05-02	English
4SC AG: 4SC AG: Dr Jorg Neermann announces resignation from Supervisory Board Board/Management Information	2012-05-02	English
Press Release 4SC AG: 4SC receives milestone payment from research collaboration with SKK Regulatory Filings	2012-04-30	English
Press Release 4SC AG: 4SC Discovery and CRELUX enter into strategic alliance Regulatory Filings	2012-04-18	English
Press Release 4SC AG: 4SC to present at two upcoming investor conferences Report Publication Announcement	2012-04-17	English
Press Release 4SC AG: Henkel and 4SC Discovery start research collaboration in compound screening Regulatory Filings	2012-04-02	English
4SC Announces Financial Results 2011: Earnings Release FY 2011	2012-03-29	English
Annual Report 2011 Annual Report FY 2011	2012-03-29	English
Annual Report 2011 Annual Report FY 2011	2012-03-29	German
4SC to host conference call and webcast on 29 March 2012 to present full year financial results Report Publication Announcement	2012-03-22	English
Press Release: 4SC receives patent protection for its oncology compound resminostat in Taiwan and three other Asian growth markets Legal Proceedings Report	2012-03-01	English
Press Release 4SC: New data on mode of action reinforce further development of vidofludimus in IBD Regulatory Filings	2012-02-17	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-02-16	German
4SC AG: Cancer compound resminostat meets primary endpoint in Phase II trial in advanced liver cancer ahead of schedule Regulatory Filings	2012-01-19	English
4SC AG: 4SC's cancer compound resminostat meets primary endpoint in Phase II trial in advanced liver cancer (HCC) ahead of schedule Regulatory Filings	2012-01-19	English
Report Publication Announcement 2012 Report Publication Announcement	2012-01-09	English
Hinweis auf Quartalsfinanzbericht vom 01.01.2012 bis zum 30.09.2012 Report Publication Announcement	2012-01-09	German
Datum:09.01.2012 Report Publication Announcement	2012-01-09	German
DGAP-DD: 4SC AG english Director's Dealing	2012-01-02	English

Filings by year

2025 3 filings
2024 1 filing
2023 4 filings
2022 4 filings
2021 6 filings
2020 14 filings
2019 45 filings
2018 39 filings
2017 55 filings
2016 34 filings
2015 59 filings
2014 43 filings
2013 39 filings
2012 67 filings
2011 60 filings
2010 42 filings
2009 47 filings
2008 38 filings
2007 78 filings
2006 38 filings
2005 3 filings